Estimaciones de analistas de Wall Street para Stereotaxis, Inc. (STXS): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-10 | $-0.05 | ||
| 2026-08-11 | $-0.05 | $-0.05 | +0.0% |
| 2026-05-12 | $-0.03 | $-0.04 | +25.0% |
| 2026-03-09 | $-0.06 | $-0.06 | +0.0% |
| 2025-11-11 | $-0.03 | $-0.06 | +50.0% |
| 2025-08-07 | $-0.05 | $-0.07 | +28.6% |
| 2025-05-12 | $-0.07 | $-0.07 | +0.0% |
| 2025-03-03 | $-0.09 | $-0.06 | -50.0% |
Ratios de valoración
| Precio / Valor contable | 6.88 |
| EV / EBITDA | -5.77 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $32.2M | $31.1M | $29.3M | $28.9M | $26.6M | $35.0M | $28.1M | $26.8M | $26.9M | $32.4M |
| Coste de Ventas | $7.5M | $10.8M | $5.7M | $6.1M | $7.7M | $11.8M | $9.7M | $11.9M | $12.3M | $15.3M |
| Beneficio Bruto | $24.6M | $20.4M | $23.6M | $22.8M | $19.0M | $23.2M | $18.5M | $14.9M | $14.6M | $17.1M |
| I+D | $5.5M | $4.8M | $8.2M | $9.0M | $8.1M | $10.2M | $10.6M | $10.3M | $9.8M | $9.4M |
| Generales y Administrativos | $25.6M | $21.5M | $17.9M | $18.6M | $17.5M | $25.9M | $26.7M | $26.4M | $29.6M | $30.3M |
| Gastos Operativos | $31.1M | $26.3M | $26.1M | $27.6M | $25.7M | $36.1M | $37.2M | $36.7M | $39.3M | $39.2M |
| Beneficio Operativo | -$6.4M | -$5.9M | -$2.5M | -$4.8M | -$6.7M | -$12.9M | -$18.8M | -$21.8M | -$24.7M | -$22.1M |
| EBITDA | -$5.9M | -$5.1M | -$1.8M | -$4.7M | -$6.6M | -$10.6M | -$17.9M | -$20.1M | -$23.1M | -$20.1M |
| Gastos por Intereses | $2.5M | $179844 | $16566 | 0 | 0 | $10071 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$5.3M | -$5.9M | $116756 | -$4.6M | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$5.3M | -$5.9M | $116756 | -$4.6M | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| BPA | $-0.24 | $-0.26 | $0.00 | $-0.07 | $-0.11 | $-0.16 | $-0.26 | $-0.27 | $-0.30 | $-0.25 |
| BPA Diluido | $-0.24 | $-0.26 | $0.00 | $-0.07 | $-0.11 | $-0.16 | $-0.26 | $-0.27 | $-0.30 | $-0.25 |
| Acciones en Circulación (Diluidas) | $21.8M | $22.6M | $52.1M | $63.1M | $72.7M | $75.6M | $76.1M | $80.7M | $85.2M | $91.0M |
Precio
| Precio | $1.31 |
| Capitalización | $129M |
| Bolsa | AMEX |
| País | US |
Empresas relacionadas: ARCT · CVRX · HUMA · MDXH · NEO · OSUR · QTRX
Explorar sector: Healthcare · Medical - Instruments & Supplies
Más secciones de STXS: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones